Position in LNTH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$36,470,970
+$8,880,912 QoQ
Shares Held
328,745
-9.6% QoQ
Ownership
0.504%
of shares outstanding
% of Portfolio
42.35%
of 13F equity value
Holder Rank
#46
of 466 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Derivatives in LNTH
reported options exposure · as of Mar 31, 2026CallValue
$7,585,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BRIGADE CAPITAL MANAGEMENT, LP holds $36,470,970 across 1 Drug Manufacturers - Specialty & Generic name. LNTH ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LNTH |
Lantheus Holdings, Inc.
This page
|
328,745 | $36,470,970 |
All Filings in LNTH
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $36,470,970 | 328,745 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $27,590,058 | 363,745 | Shares | Sole | 2026-05-15 | |
| 2026-03-31 | $7,585,000 | 100,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $8,492,245 | 127,607 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,225,335 | 316,345 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $11,717,849 | 143,145 | Shares | Sole | 2025-08-14 | |
| No filing history on record for this holder in this stock. | ||||||